Home › Research › Lewy body dementia
Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study
Patricia Diaz‐Galvan, Scott A. Przybelski, Timothy G. Lesnick, Melissa Erin Murray, Aivi T. Nguyen, Ross R. Reichard, Dennis W. Dickson, Daisuke Ono et al.. Movement Disorders, 2025-06-23
Topic: Brain proteins, microglia and lab models
Plain-language summary
The LBD-present group had higher QSM values in the SNc (P = 0.008) than the LBD-absent group with no differences in SNr. QSM values of the SNc distinguished LBD-present and LBD-absent cases with good accuracy (AUC = 0.74) and correlated with the presence of parkinsonism and parkinsonism severity. This study provides neuropathological confirmation of the utility of SNc QSM as an in vivo biomarker of Lewy-related pathology. Imaging evidence of abnormal iron deposition in the SNc could potentially serve as a biomarker for inclusion in emerging research frameworks aimed at defining individuals with LBD based on their biological characteristics. Ultimately, this could facilitate more precise diagnoses and guide treatment strategies in LBD. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 13 participants. This study found that higher QSM values in the substantia nigra pars compacta distinguished Lewy body disease cases with good accuracy and correlated with parkinsonism severity, providing neuropathological confirmation of a biomarker. Reported effect size: AUC = 0.74.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Diaz‐Galvan, P., Przybelski, S. A., Lesnick, T. G., Murray, M. E., Nguyen, A. T., Reichard, R. R., et al. (2025). Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study. Movement Disorders. https://doi.org/10.1002/mds.30265
Vancouver
Diaz‐Galvan P, Przybelski SA, Lesnick TG, Murray ME, Nguyen AT, Reichard RR, et al. Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study. Movement Disorders. 2025. doi:10.1002/mds.30265. PMID: 40545947.
BibTeX
@article{diazgalvan2025-40545947,
author = {Diaz‐Galvan, Patricia and Przybelski, Scott A. and Lesnick, Timothy G. and Murray, Melissa Erin and Nguyen, Aivi T. and Reichard, Ross R. and Dickson, Dennis W. and Ono, Daisuke and others},
title = {{Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study}},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.30265},
pmid = {40545947},
url = {https://doi.org/10.1002/mds.30265}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The LBD-present group had higher QSM values in the SNc (P = 0.008) than the LBD-absent group with no differences in SNr.
- QSM values of the SNc distinguished LBD-present and LBD-absent cases with good accuracy (AUC = 0.74) and correlated with the presence of parkinsonism and parkinsonism severity.
- This study provides neuropathological confirmation of the utility of SNc QSM as an in vivo biomarker of Lewy-related pathology.
- Imaging evidence of abnormal iron deposition in the SNc could potentially serve as a biomarker for inclusion in emerging research frameworks aimed at defining individuals with LBD based on their biological characteristics.
- Ultimately, this could facilitate more precise diagnoses and guide treatment strategies in LBD. © 2025 The Author(s).
Why it matters
This study found that higher QSM values in the substantia nigra pars compacta distinguished Lewy body disease cases with good accuracy and correlated with parkinsonism severity, providing neuropathological confirmation of a biomarker. It could facilitate more precise diagnoses but no treatment or cure.
Study details
- Study designcohort study
- Participants13
- Effect sizeAUC = 0.74
- Evidence strengthModerate
How this study scored 61/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Movement Disorders) |
| Journal's citation record | 3 / 4 | Movement Disorders: journal h-index 281 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 13 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 9 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 5.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Kejal Kantarci: h-index 103 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Mayo Clinic: institution h-index 1,606 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40545947) |
| Free to read | 2 / 2 | Free to read |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Related studies in Lewy body dementia from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.